Jacques Defaye

Title: Jacques Defaye: Innovator in Cyclodextrin Applications

Introduction

Jacques Defaye is a notable inventor based in St. Ismier, France. He has made significant contributions to the field of chemistry, particularly in the use of natural cyclodextrins and their derivatives. His work focuses on enhancing the solubilization of platelet anti-aggregating agents, which has important implications for medical applications.

Latest Patents

Jacques Defaye holds a patent for the use of natural cyclodextrins and their derivatives for the solubilization of platelet anti-aggregating agents from the family of Ginkgolides. The patent describes a method that utilizes cyclodextrins that comply with a specific formula, where n can be 6, 7, or 8. The R groups in the formula can represent hydroxyl or sulfhydryl groups derived from monosaccharides or oligosaccharides. The preferred Ginkgolide in this invention is Ginkgolide B. This innovative approach has the potential to improve the effectiveness of certain medical treatments.

Career Highlights

Jacques Defaye is associated with the Commissariat à l'Énergie Atomique et aux Énergies Alternatives, a prominent research institution in France. His work there has allowed him to explore and develop his ideas in a collaborative environment, contributing to advancements in the field of chemistry and pharmaceuticals.

Collaborations

Throughout his career, Jacques has worked alongside esteemed colleagues such as Bruno Perly and Florence Djedaini-Pilard. These collaborations have enriched his research and have led to significant advancements in their shared field of study.

Conclusion

Jacques Defaye's contributions to the field of cyclodextrin applications highlight his innovative spirit and dedication to advancing medical science. His patent on the solubilization of platelet anti-aggregating agents showcases the potential of natural compounds in therapeutic applications.